140 related articles for article (PubMed ID: 32031474)
41. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
[TBL] [Abstract][Full Text] [Related]
42. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
43. Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection.
Chen X; Zhang B; Yin X; Ren Z; Qiu S; Zhou J
J Cancer Res Clin Oncol; 2013 May; 139(5):773-81. PubMed ID: 23377952
[TBL] [Abstract][Full Text] [Related]
44. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1.
Giunchedi P; Maestri M; Gavini E; Dionigi P; Rassu G
Expert Opin Drug Deliv; 2013 May; 10(5):679-90. PubMed ID: 23406440
[TBL] [Abstract][Full Text] [Related]
45. Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation.
Kluger MD; Halazun KJ; Barroso RT; Fox AN; Olsen SK; Madoff DC; Siegel AB; Weintraub JL; Sussman J; Brown RS; Cherqui D; Emond JC
Liver Transpl; 2014 May; 20(5):536-43. PubMed ID: 24493271
[TBL] [Abstract][Full Text] [Related]
46. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
[TBL] [Abstract][Full Text] [Related]
47. Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 μm. Safety and efficacy study.
Malagari K; Pomoni M; Moschouris H; Kelekis A; Charokopakis A; Bouma E; Spyridopoulos T; Chatziioannou A; Sotirchos V; Karampelas T; Tamvakopoulos C; Filippiadis D; Karagiannis E; Marinis A; Koskinas J; Kelekis DA
Cardiovasc Intervent Radiol; 2014 Feb; 37(1):165-75. PubMed ID: 24263774
[TBL] [Abstract][Full Text] [Related]
48. Improved Local Tumor Control and Survival Rates by Obtaining a 3D-Safety Margin in Superselective Transarterial Chemoembolization for Small Hepatocellular Carcinoma.
Kattipatanapong T; Nishiofuku H; Tanaka T; Sato T; Masada T; Tatsumoto S; Matsumoto T; Kichikawa K
Cardiovasc Intervent Radiol; 2020 Mar; 43(3):423-433. PubMed ID: 31720806
[TBL] [Abstract][Full Text] [Related]
49. Transarterial chemoembolization for hepatocellular carcinoma: An old method, now flavor of the day.
Boulin M; Delhom E; Pierredon-Foulongne MA; Cercueil JP; Guiu B
Diagn Interv Imaging; 2015 Jun; 96(6):607-15. PubMed ID: 25998996
[TBL] [Abstract][Full Text] [Related]
50. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
Xue T; Le F; Chen R; Xie X; Zhang L; Ge N; Chen Y; Wang Y; Zhang B; Ye S; Ren Z
Med Oncol; 2015 Mar; 32(3):64. PubMed ID: 25682389
[TBL] [Abstract][Full Text] [Related]
51. [Transarterial chemoembolization (TAE) with degradable starch microspheres (DSM) in advanced hepatocellular carcinoma].
Horikiri N; Yamakado K; Nakatsuka A; Ishii T; Matsushima N; Tanaka N; Takeda K
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1493-6. PubMed ID: 11707962
[TBL] [Abstract][Full Text] [Related]
52. Arterial embolization of massive hepatocellular carcinoma with lipiodol and gelatin sponge.
Xie LL; Sun CJ; Li XD; Wang YH; Wang CE
Indian J Cancer; 2015 Feb; 51 Suppl 2():e49-51. PubMed ID: 25712844
[TBL] [Abstract][Full Text] [Related]
53. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.
Marelli L; Stigliano R; Triantos C; Senzolo M; Cholongitas E; Davies N; Tibballs J; Meyer T; Patch DW; Burroughs AK
Cardiovasc Intervent Radiol; 2007; 30(1):6-25. PubMed ID: 17103105
[TBL] [Abstract][Full Text] [Related]
54. Transvascular therapy of Hepatocellular Carcinoma (HCC), status and developments.
Gnutzmann D; Kortes N; Sumkauskaite M; Schmitz A; Weiss KH; Radeleff B
Minim Invasive Ther Allied Technol; 2018 Apr; 27(2):69-80. PubMed ID: 29381102
[TBL] [Abstract][Full Text] [Related]
55. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
[TBL] [Abstract][Full Text] [Related]
56. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma.
Park GC; Lee SG; Yoon YI; Sung KB; Ko GY; Gwon DI; Jung DH; Jung YK
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):244-251. PubMed ID: 32414576
[TBL] [Abstract][Full Text] [Related]
57. Transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinoma.
Liu YS; Ou MC; Tsai YS; Lin XZ; Wang CK; Tsai HM; Chuang MT
Korean J Radiol; 2015; 16(1):125-32. PubMed ID: 25598680
[TBL] [Abstract][Full Text] [Related]
58. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy.
Xu LF; Sun HL; Chen YT; Ni JY; Chen D; Luo JH; Zhou JX; Hu RM; Tan QY
J Gastroenterol Hepatol; 2013 Mar; 28(3):456-63. PubMed ID: 23216261
[TBL] [Abstract][Full Text] [Related]
59. Large hepatocellular carcinomas: treatment with transarterial chemoembolization alone or in combination with percutaneous cryoablation.
Cui W; Fan W; Huang K; Wang Y; Lu M; Yao W; Li J
Int J Hyperthermia; 2018; 35(1):239-245. PubMed ID: 30200796
[TBL] [Abstract][Full Text] [Related]
60. Phase I Dose-Escalation Study of Tirapazamine Chemoembolization for Unresectable Early- and Intermediate-Stage Hepatocellular Carcinoma.
Liu CH; Peng CM; Hwang JI; Liang PC; Chen PJ; Abi-Jaoudeh N; Giiang LH; Tyan YS
J Vasc Interv Radiol; 2022 Aug; 33(8):926-933.e1. PubMed ID: 35504436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
